NRXS
NeurAxis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.96
−1.81%Leverage
- Debt / equity
- 0.04x
- Net debt / equity
- -1.19x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.04x
- Net debt / EBITDA
- 1.07x
Liquidity & coverage
- Current ratio
- 3.04x
- Quick ratio
- 2.95x
- Cash ratio
- 2.69x
- Interest coverage
- -148.01x
- EBITDA / interest
- -144.52x
- Working capital
- $6.3M
Cash & dividend
- FCF / debt
- -20.16x
- Cash flow / debt
- -20.12x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026